RecruitingNCT04898335
Tendyne European Experience Registry
TENDyne European expeRience Registry
Sponsor
LMU Klinikum
Enrollment
400 participants
Start Date
Apr 15, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
TENDER is a multicenter, single-device, retrospective and prospective, observational study to assess safety and efficacy of the Tendyne Mitral Valve System in a real-world population.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Patients treated with the Tendyne Mitral Valve System for mitral valve disease in a commercial setting
- Patients providing written informed consent in compliance with the protocol, the ICH-GCP and all national legal and regulatory requirements
Exclusion Criteria1
- Patients not providing written informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICETendyne Mitral Valve System
Tendyne Mitral Valve System for mitral valve disease in a commercial setting
Locations(30)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04898335
Related Trials
A Clinical Study of GeminiOne TEER System for the Treatment of Severe, Symptomatic MR.
NCT070865341 location
Cephea Early Feasibility Study
NCT0506100422 locations
Abbott Cephea Mitral Valve Disease Registry
NCT0706967319 locations
STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant
NCT069014661 location
STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant
NCT070071431 location